about
Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agentsIn vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent.Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methodsIn vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.Canadian clinical practice guidelines for invasive candidiasis in adults.Genitourinary fungal infections: a therapeutic conundrum.Cloning and characterization of the gene cluster required for beauvericin biosynthesis in Fusarium proliferatum.Human pharmacogenomic variations and their implications for antifungal efficacy.Aspergillosis in a 24-week newborn: a case report.Synthesis and antifungal activity of novel triazole compounds containing piperazine moiety.Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adultsNovel approaches to antifungal prophylaxis.Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.Emerging azole antifungals.In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates.Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.Design and synthesis of new fluconazole analogues.Pharmacological agents in development for invasive aspergillosis.Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors.Quantitative evaluation of cryptococcal pathogenesis and antifungal drugs using a silkworm infection model with Cryptococcus neoformans.Structure-based design, synthesis, and antifungal activity of new triazole derivatives.Modulation of Cyp450, ALS1 and COX-2 signaling pathways induced by Candida albicans infection via novel antifungal agents.Synthesis and Biological Activity of Sterol 14α-Demethylase and Sterol C24-Methyltransferase InhibitorsDesign and Antimicrobial Evaluation of 1-Methylimidazole Derivatives as New Antifungal and Antibacterial Agents
P2860
Q26863344-0D1B27C1-6641-4976-A601-6FAE61357169Q28345161-8562A496-017E-424B-BBC3-D886BE1FF2ECQ30452376-50DCE3C6-8287-48B2-8CA6-CACFA6861752Q34041745-7EDFF80E-67FF-47F7-8C05-135F4FED4BA3Q34110440-BC8337BA-32D7-4CDB-A355-6794B688CDEFQ34237335-74C7F343-534D-459D-9DDE-8B6711EDA5D7Q34390174-B8A7A5B5-96E8-4540-90A0-CCF87C3FF229Q34801546-2EFC0CD2-5427-49F4-9CEA-54220B3BD551Q35070838-FDFF472B-F1EF-4C3A-BE7B-EEA87C2F89D2Q35122150-86B1DBDC-2D26-4682-BEA4-9D48400A8BC1Q35218682-014462A9-866C-4BE1-9CF8-35F0747A522CQ35685548-383C8119-5F30-49E7-8099-B7D8DFF01F3BQ35790799-F0BAF81E-2DDE-425D-BF5F-AFB37B59B3D4Q35825919-D9AFDDB2-59D1-4894-899A-8148333A4C1EQ36066009-6C0CC637-F7AD-409B-9E9D-7CFC1DAF52AAQ36669593-396A0D83-49BD-47C7-843D-56F548E0973CQ37119029-295DBFDE-6E23-4FEA-95B8-4BE3AEC6F1EAQ38874757-F52A2EB9-7A9E-4C7D-A6D4-C890E47A78C8Q40409386-FD2F2047-1CFD-41B4-9427-69750B53E3A2Q40733878-9D0E619D-7D83-4719-B5D4-C63102EFF3BBQ41004012-87CAB954-9961-4406-99A5-50D3DB8C73D2Q42015429-AAD92955-FCFA-409C-8202-FEB78055729CQ42735722-7D11B725-C219-4032-8C31-450919FFC4E4Q52647827-464A550A-BE5C-4866-B19B-AFA3F876433DQ58842234-C710E79F-8061-4DD7-9569-CFCD163F6FC8Q59285092-81B0766B-79EA-4579-B294-845EE788BBB0
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Novel triazole antifungal agents.
@ast
Novel triazole antifungal agents.
@en
Novel triazole antifungal agents.
@nl
type
label
Novel triazole antifungal agents.
@ast
Novel triazole antifungal agents.
@en
Novel triazole antifungal agents.
@nl
prefLabel
Novel triazole antifungal agents.
@ast
Novel triazole antifungal agents.
@en
Novel triazole antifungal agents.
@nl
P2093
P2860
P356
P1476
Novel triazole antifungal agents.
@en
P2093
P2860
P304
P356
10.1517/13543784.9.3.593
P407
P577
2000-03-01T00:00:00Z